Literature DB >> 19372692

(+/-)3,4-Methylenedioxymethamphetamine (MDMA) dose-dependently impairs spatial learning in the morris water maze after exposure of rats to different five-day intervals from birth to postnatal day twenty.

Charles V Vorhees1, Tori L Schaefer, Matthew R Skelton, Curtis E Grace, Nicole R Herring, Michael T Williams.   

Abstract

During postnatal days (PD) 11-20, (+/-)3,4-methylenedioxymethamphetamine (MDMA) treatment impairs egocentric and allocentric learning, and reduces spontaneous locomotor activity; however, it does not have these effects during PD 1-10. How the learning impairments relate to the stress hyporesponsive period (SHRP) is unknown. To test this association, the preweaning period was subdivided into 5-day periods from PD 1-20. Separate pups within each litter were injected subcutaneously with 0, 10, 15, 20, or 25 mg/kg MDMA x4/day on PD 1-5, 6-10, 11-15, or 16-20, and tested as adults. The 3 highest MDMA dose groups showed reduced locomotor activity during the first 10 min (of 60 min), especially in the PD 1-5 and 6-10 dosing regimens. MDMA groups in all dosing regimens showed impaired allocentric learning in the Morris water maze (on acquisition and reversal, all MDMA groups were affected; on the small platform phase, the 2 high-dose groups were affected). No effects of MDMA were found on anxiety (elevated zero maze), novel object recognition, or egocentric learning (although a nonsignificant trend was observed). The Morris maze results did not support the idea that the SHRP is critical to the effects of MDMA on allocentric learning. However, since no effects on egocentric learning were found, but were apparent after PD 11-20 treatment, the results show that these 2 forms of learning have different exposure-duration sensitivities. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19372692      PMCID: PMC2888301          DOI: 10.1159/000207499

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  43 in total

Review 1.  Maturation of the adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period.

Authors:  R M Sapolsky; M J Meaney
Journal:  Brain Res       Date:  1986-03       Impact factor: 3.252

2.  Treatment with MDMA from P11-20 disrupts spatial learning and path integration learning in adolescent rats but only spatial learning in older rats.

Authors:  Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Psychopharmacology (Berl)       Date:  2006-10-03       Impact factor: 4.530

3.  Effect of neonatal handling on age-related impairments associated with the hippocampus.

Authors:  M J Meaney; D H Aitken; C van Berkel; S Bhatnagar; R M Sapolsky
Journal:  Science       Date:  1988-02-12       Impact factor: 47.728

4.  Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine).

Authors:  E Ho; L Karimi-Tabesh; G Koren
Journal:  Neurotoxicol Teratol       Date:  2001 Nov-Dec       Impact factor: 3.763

5.  Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood.

Authors:  Martha A Cohen; Matthew R Skelton; Tori L Schaefer; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  Synapse       Date:  2005-09-01       Impact factor: 2.562

6.  Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress.

Authors:  Michael T Williams; LaRonda L Morford; Sandra L Wood; Stephanie L Rock; Anne E McCrea; Masao Fukumura; Tanya L Wallace; Harry W Broening; Mary S Moran; Charles V Vorhees
Journal:  Brain Res       Date:  2003-04-04       Impact factor: 3.252

7.  Hyperactivity and spatial maze learning impairment of adult rats with temporary neonatal hypothyroidism.

Authors:  M Akaike; N Kato; H Ohno; T Kobayashi
Journal:  Neurotoxicol Teratol       Date:  1991 May-Jun       Impact factor: 3.763

8.  Suppression of hippocampal neurogenesis is associated with developmental stage, number of perinatal seizure episodes, and glucocorticosteroid level.

Authors:  H Liu; J Kaur; K Dashtipour; R Kinyamu; C E Ribak; L K Friedman
Journal:  Exp Neurol       Date:  2003-11       Impact factor: 5.330

9.  Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine.

Authors:  J T Winslow; T R Insel
Journal:  J Pharmacol Exp Ther       Date:  1990-07       Impact factor: 4.030

10.  Web-based method for translating neurodevelopment from laboratory species to humans.

Authors:  Barbara Clancy; Brandon Kersh; James Hyde; Richard B Darlington; K J S Anand; Barbara L Finlay
Journal:  Neuroinformatics       Date:  2007
View more
  17 in total

1.  Distinct periods of developmental sensitivity to the effects of 3,4-(±)-methylenedioxymethamphetamine (MDMA) on behaviour and monoamines in rats.

Authors:  Matthew R Skelton; Devon L Graham; Tori L Schaefer; Curtis E Grace; Amanda A Braun; Lindsey N Burns; Robyn M Amos-Kroohs; Michael T Williams; Charles V Vorhees
Journal:  Int J Neuropsychopharmacol       Date:  2011-06-28       Impact factor: 5.176

2.  Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy.

Authors:  Lynn T Singer; Derek G Moore; Sarah Fulton; Julia Goodwin; John J D Turner; Meeyoung O Min; Andrew C Parrott
Journal:  Neurotoxicol Teratol       Date:  2012-03-03       Impact factor: 3.763

Review 3.  Assessing spatial learning and memory in rodents.

Authors:  Charles V Vorhees; Michael T Williams
Journal:  ILAR J       Date:  2014

4.  MDMA enhances hippocampal-dependent learning and memory under restrictive conditions, and modifies hippocampal spine density.

Authors:  Sònia Abad; Alberto Fole; Nuria del Olmo; David Pubill; Mercè Pallàs; Fèlix Junyent; Jorge Camarasa; Antonio Camins; Elena Escubedo
Journal:  Psychopharmacology (Berl)       Date:  2013-10-26       Impact factor: 4.530

5.  Prenatal oxycodone exposure impairs spatial learning and/or memory in rats.

Authors:  Chris P Davis; La'tonya M Franklin; Gabriel S Johnson; Lisa M Schrott
Journal:  Behav Brain Res       Date:  2010-03-20       Impact factor: 3.332

6.  One-year outcomes of prenatal exposure to MDMA and other recreational drugs.

Authors:  Lynn T Singer; Derek G Moore; Meeyoung O Min; Julia Goodwin; John J D Turner; Sarah Fulton; Andrew C Parrott
Journal:  Pediatrics       Date:  2012-08-20       Impact factor: 7.124

7.  The role of adenosine receptor agonist and antagonist on Hippocampal MDMA detrimental effects; a structural and behavioral study.

Authors:  Fatemeh Kermanian; Mehdi Mehdizadeh; Mansureh Soleimani; Ali Reza Ebrahimzadeh Bideskan; Majid Asadi-Shekaari; Hamed Kheradmand; Hossein Haghir
Journal:  Metab Brain Dis       Date:  2012-09-09       Impact factor: 3.584

Review 8.  Cincinnati water maze: A review of the development, methods, and evidence as a test of egocentric learning and memory.

Authors:  Charles V Vorhees; Michael T Williams
Journal:  Neurotoxicol Teratol       Date:  2016-08-18       Impact factor: 3.763

9.  A Systematic Review of the MDMA Model to Address Social Impairment in Autism.

Authors:  Devahuti Chaliha; John C Mamo; Matthew Albrecht; Virginie Lam; Ryu Takechi; Mauro Vaccarezza
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

10.  Evaluation of Bcl-2 Family Gene Expression in Hippocampus of 3, 4-methylenedioxymethamphetamine Treated Rats.

Authors:  Sara Soleimani Asl; Mohammad Hassan Farhadi; Kazem Moosavizadeh; Ali Samadi Kuchak Saraei; Mansoure Soleimani; Seid Behnameldin Jamei; Mohammad Taghi Joghataei; Alireza Samzadeh-Kermani; Hamed Hashemi-Nasl; Mehdi Mehdizadeh
Journal:  Cell J       Date:  2011-12-22       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.